SCHEMBL6207996

SCHEMBL6207996

CCCCc1c(O[SiH](C)C)[nH]c2ccccc12

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 5/20 0.49
▸ HSD17B10 Q99714 4/20 0.49
▸ ALDH1A1 P00352 4/20 0.49
▸ HPGD P15428 3/20 0.49
▸ TSHR P16473 2/20 0.46
▸ CYP3A4 P08684 2/20 0.46
▸ CYP1A2 P05177 1/20 0.46
▸ RAB9A P51151 1/20 0.46
▸ GAA P10253 1/20 0.45
▸ POLB P06746 1/20 0.44
▸ HTR6 P50406 3/20 0.43
▸ GABRP O00591 1/20 0.43
▸ GABRD O14764 1/20 0.43
▸ GABRA1 P14867 1/20 0.43
▸ IDO1 P14902 1/20 0.43
▸ GABRB1 P18505 1/20 0.43
▸ GABRG2 P18507 1/20 0.43
▸ GABRB3 P28472 1/20 0.43
▸ GABRA5 P31644 1/20 0.43
▸ GABRA3 P34903 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27623557 0.77 KDM4E (0.52) KDM4EHSD17B10ALDH1A1HPGDTSHR
SCHEMBL8998008 0.76 KDM4E (0.72) KDM4EHSD17B10ALDH1A1HPGDTSHR
SCHEMBL28785846 0.73 KDM4E (0.55) KDM4EHSD17B10ALDH1A1HPGDTSHR
SCHEMBL27691174 0.73 KDM4E (0.63) KDM4EHSD17B10ALDH1A1HPGDTSHR
SCHEMBL28286983 0.72 HTR2A (0.66) KDM4EHSD17B10ALDH1A1HPGDDRD2
SCHEMBL28674730 0.72 CHRNB2 (0.59) KDM4EHSD17B10ALDH1A1HPGDTSHR
SCHEMBL4921978 0.71 KDM4E (0.70) KDM4EHSD17B10ALDH1A1HPGDTSHR
SCHEMBL28987798 0.71 CHRNB2 (0.58) KDM4EHSD17B10ALDH1A1HPGDTSHR
SCHEMBL8444672 0.70 KDM4E (0.68) KDM4EHSD17B10ALDH1A1HPGDTSHR
SCHEMBL5409935 0.70 CHRNB2 (0.60) KDM4EHSD17B10ALDH1A1HPGDTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1565455-A1 INDOLYL PYRAZINONE DERIVATIVES USEFUL FOR TREATING HYPER-PROLIFERATIVE DISORDERS AND DISEASES ASSOCIATED WITH ANGIOGENESIS Bayer Pharmaceuticals Corporation (US) 2005-08-24 — — EP disclosed
WO-2004043950-A1 INDOLYL PYRAZINONE DERIVATIVES USEFUL FOR TREATING HYPER-PROLIFERATIVE DISORDERS AND DISEASES ASSOCIATED WITH ANGIOGENESIS BAYER PHARMACEUTICALS CORPORATION (US) 2004-05-27 — — WO disclosed
Send feedback